Scientific problem
END-STAGE RENAL DISEASE, INFECTIOUS DISEASE, KIDNEY, ORGAN REJECTION
Kidney transplantation is the gold standard of treatment for patients with end-stage renal disease. After transplantation, immunosuppressive drugs are crucial for reducing the risk of organ rejection. Despite this desired effect, the compromised immunity of the recipient leads to an increased risk of infectious disease. Moreover, current immunosuppression regimens are unable to sufficiently control allorecognition, which leads to graft rejection [